Share on LinkedInShare on LinkedIn

ARTICLE · 13 JANUARY 2015

USPTO Issues Final Patent Term Adjustment Rules Under Novartis

The USPTO has published final Patent Term Adjustment (PTA) rules addressing the treatment of Requests for Continued Examination (RCEs) under the Federal Circuit decision in Novartis v. Lee, which I discussed here.

United StatesIntellectual Property

The USPTO has published final Patent Term Adjustment (PTA) rules addressing the treatment of Requests for Continued Examination (RCEs) under the Federal Circuit decision in Novartis v. Lee, which I discussed here. The final rules create a new type of deduction for "Applicant delay" that will apply to applications in which an RCE is filed on or after March 10, 2015.

The PTA/RCE Issue

In Novartis, the Federal Circuit determined that the USPTO had incorrectly interpreted 35 USC § 154(b)(1)(B)(i) as applied to applications in which an RCE was filed. That portion of the PTA statute provides for an award of PTA when the USPTO fails to issue a patent within three years, and reads as follows:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from